In addition to its global leadership position in biosimilars, generic antibiotics, dermatology and drugs for transplantation, Sandoz, a division of Novartis, has a large product portfolio in Canada, including four biosimilars and over 700 generic products formulated with more than 280 molecules and medicinal ingredients and covering multiple therapeutic sectors. We are proud to play a vital role in the Canadian healthcare system. In 2019, Sandoz products were prescribed more than 65 million times across the country.

Our Purpose is to pioneer access for Canadian patients and help them improve or extend their lives.

Our Ambition is to position Sandoz Canada as THE leader in Bio-Generics powered by our portfolio, pipeline and people to serve as a trusted partner to pharmacies, hospitals, physicians, governments and payers.

VIRTUAL PASSPORT CODE: SAN845